Daridorexant, an Orexin Receptor Antagonist for the Management of Insomnia.

Author: DimaLorena, NajibJadwiga, ToderikaYuliana

Paper Details 
Original Abstract of the Article :
Insomnia is a common sleep disorder that is diagnosed primarily by patients' subjective reported symptoms. Daridorexant is a new dual orexin receptor antagonist that was recently approved by Food and Drug Administration for insomnia characterized by difficulty falling asleep and/or maintaining sleep...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/37449930

データ提供:米国国立医学図書館(NLM)

Daridorexant: A New Hope for Insomnia

Insomnia, a common sleep disorder that can feel as endless as a desert night, is often characterized by difficulty falling asleep and/or staying asleep. This study explores a new treatment, daridorexant, a dual orexin receptor antagonist, approved by the Food and Drug Administration for the management of insomnia.

Daridorexant: A Promising New Treatment for Insomnia

The study highlights the potential of daridorexant in addressing insomnia. It's like discovering a new oasis in the desert, providing relief and restoring restful sleep.

Finding Relief from Insomnia

This research offers hope for individuals struggling with insomnia. Daridorexant, like a soothing balm, provides a new avenue for managing this prevalent sleep disorder.

Dr.Camel's Conclusion

This study introduces a new treatment option for insomnia, offering a potential solution to a common and often debilitating sleep disorder. It's like a guiding star in the night sky, leading us towards a more peaceful and restful sleep.
Date :
  1. Date Completed 2023-07-17
  2. Date Revised 2023-07-18
Further Info :

Pubmed ID

37449930

DOI: Digital Object Identifier

00045391-202308000-00007

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.